Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 27;13:2305–2315. doi: 10.2147/OPTH.S233125

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Spadea and Giovannetti.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The figure shows slit lamp examination of a female patient 54 yrs old who had developed an evident haze 2 months after PRK. At that time her DCVA was 20/30 with −0.50sph=−3.50cyl (130°). After 8 months she underwent scraping of the stromal surface and application of mytomicin C. The images show left eye slit lamp photographs before (left) and 6 months after (right) the treatment. The corneal opacity is remarkably reduced, and her DCVA is now 20/25 with −0.50sph=−0.50cyl (150°).